Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sayin

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|March 13, 2024
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less <i>KRAS</i> and More <i>EGFR</i> Mutations Compared to Advanced AdenocarcinomasJennie Petterson, Dyar Mustafa, Sashidar Bandaru, et al.
Plos One|August 13, 2013
Zinc finger protein 148 is dispensable for primitive and definitive hematopoiesis in miceAnna Nilton, Volkan I Sayin, Anna Staffas, et al.
Cell Metabolism|February 12, 2013
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonistSama I Sayin, Annika Wahlström, Jenny Felin, et al.
Plos One|May 26, 2018
Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion miceDennis R Petersen, Laura M Saba, Volkan I Sayin, et al.
Free Radical Biology & Medicine|September 9, 2022
Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1Rita Moreno, Laura Casares, Maureen Higgins, et al.
Cell Reports|August 10, 2023
A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosisHaidong Yao, Xue Chen, Ting Wang, et al.
Frontiers in Oncology|February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Johanna Svensson, George-Alehandro Saad, et al.
Cell Metabolism|December 10, 2019
Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino AcidsSarah E LeBoeuf, Warren L Wu, Triantafyllia R Karakousi, et al.
Plos One|February 14, 2013
Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatmentVolkan I Sayin, Anna Nilton, Mohamed X Ibrahim, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|March 13, 2024
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less <i>KRAS</i> and More <i>EGFR</i> Mutations Compared to Advanced AdenocarcinomasJennie Petterson, Dyar Mustafa, Sashidar Bandaru, et al.
Plos One|August 13, 2013
Zinc finger protein 148 is dispensable for primitive and definitive hematopoiesis in miceAnna Nilton, Volkan I Sayin, Anna Staffas, et al.
Cell Metabolism|February 12, 2013
Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonistSama I Sayin, Annika Wahlström, Jenny Felin, et al.
Plos One|May 26, 2018
Elevated Nrf-2 responses are insufficient to mitigate protein carbonylation in hepatospecific PTEN deletion miceDennis R Petersen, Laura M Saba, Volkan I Sayin, et al.
Free Radical Biology & Medicine|September 9, 2022
Biotinylation of an acetylenic tricyclic bis(cyanoenone) lowers its potency as an NRF2 activator while creating a novel activity against BACH1Rita Moreno, Laura Casares, Maureen Higgins, et al.
Cell Reports|August 10, 2023
A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosisHaidong Yao, Xue Chen, Ting Wang, et al.
Frontiers in Oncology|February 27, 2023
Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Anna Rohlin, Ella A Eklund, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancerNikita Dutta, Johanna Svensson, George-Alehandro Saad, et al.
Cell Metabolism|December 10, 2019
Activation of Oxidative Stress Response in Cancer Generates a Druggable Dependency on Exogenous Non-essential Amino AcidsSarah E LeBoeuf, Warren L Wu, Triantafyllia R Karakousi, et al.
Plos One|February 14, 2013
Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatmentVolkan I Sayin, Anna Nilton, Mohamed X Ibrahim, et al.
Pageof 7